Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
COVID-19-Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group.
Can J Cardiol. 2021 Aug;37(8):1165-1174. doi: 10.1016/j.cjca.2020.11.007. Epub 2020 Nov 26.
Can J Cardiol. 2021.
PMID: 33248208
Free PMC article.
Organized sporting events, from recreational to the Olympic level, have been cancelled to both mitigate the spread of COVID-19 and protect athletes and highly active individuals from potential acute and long-term infection-associated harms. COVID-19 infection has been asso …
Organized sporting events, from recreational to the Olympic level, have been cancelled to both mitigate the spread of COVID-19 and protect a …
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.
Kingwell E, Koch M, Leung B, Isserow S, Geddes J, Rieckmann P, Tremlett H.
Kingwell E, et al. Among authors: isserow s.
Neurology. 2010 Jun 1;74(22):1822-6. doi: 10.1212/WNL.0b013e3181e0f7e6. Epub 2010 Apr 28.
Neurology. 2010.
PMID: 20427751
Free PMC article.
A dose-response effect was not apparent. Findings emphasize the importance of monitoring; the long-term effects of mitoxantrone in multiple sclerosis require investigation....
A dose-response effect was not apparent. Findings emphasize the importance of monitoring; the long-term effects of mitoxantrone in mu …
Item in Clipboard
Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.
Huckell VF, Bernstein V, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A.
Huckell VF, et al. Among authors: isserow s.
Can J Cardiol. 1997 Feb;13(2):173-82.
Can J Cardiol. 1997.
PMID: 9070169
Review.
Over the past 10 years, several clinical studies have concluded that, in patients already receiving conventional therapies, angiotensin-converting enzyme (ACE) inhibitors further reduce the risk of death following myocardial infarction (MI). Post-MI ACE inhibitors have proven to …
Over the past 10 years, several clinical studies have concluded that, in patients already receiving conventional therapies, angiotensin-conv …
Item in Clipboard
Cite
Cite